share_log

Strong Week for HCR (SHSE:688500) Shareholders Doesn't Alleviate Pain of One-year Loss

Strong Week for HCR (SHSE:688500) Shareholders Doesn't Alleviate Pain of One-year Loss

HCR(SHE:688500)股東的強勁一周沒有減輕一年虧損的痛苦
Simply Wall St ·  2023/02/09 10:21

It is a pleasure to report that the HCR Co., Ltd (SHSE:688500) is up 54% in the last quarter. But that doesn't change the reality of under-performance over the last twelve months. In fact, the price has declined 13% in a year, falling short of the returns you could get by investing in an index fund.

這是一種高興地報告, HCR 有限公司 上個季度上漲了 54%。但是,這並不能改變過去十二個月內績效不佳的現實。事實上,價格在一年內下跌了 13%,低於投資於指數基金可能獲得的回報。

While the last year has been tough for HCR shareholders, this past week has shown signs of promise. So let's look at the longer term fundamentals and see if they've been the driver of the negative returns.

儘管去年對 HCR 股東來說是艱難的,但過去一周顯示出了承諾的跡象。因此,讓我們看看長期的基本面,看看它們是否已經成為負回報的驅動力。

Check out our latest analysis for HCR

查看我們有關 HCR 的最新分析

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

釋義本傑明·格雷厄姆:在短期內,市場是一台投票機,但從長遠來看,這是一個稱重機。檢視市場情緒隨時間變化的一種方法是查看公司股價與其每股收益(EPS)之間的互動。

HCR fell to a loss making position during the year. While this may prove temporary, we'd consider it a negative, so it doesn't surprise us that the stock price is down. Of course, if the company can turn the situation around, investors will likely profit.

年內,醫護接受者跌至虧損的位置。雖然這可能是暫時的,但我們認為這是負面的,因此股價下跌並不令我們感到驚訝。當然,如果公司可以扭轉局勢,投資者可能會獲利。

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

下圖說明 EPS 隨時間變化的方式 (按一下影像即可顯示確切值)。

earnings-per-share-growth
SHSE:688500 Earnings Per Share Growth February 9th 2023
上海股份代碼:二零二三年二月九日每股盈利增長 688500

Dive deeper into HCR's key metrics by checking this interactive graph of HCR's earnings, revenue and cash flow.

通過查看 HCR 的收入,收入和現金流的互動圖表,深入了解 HCR 的關鍵指標。

A Different Perspective

不同的角度

HCR shareholders are down 13% for the year, even worse than the market loss of 5.1%. There's no doubt that's a disappointment, but the stock may well have fared better in a stronger market. It's great to see a nice little 54% rebound in the last three months. Let's just hope this isn't the widely-feared 'dead cat bounce' (which would indicate further declines to come). It's always interesting to track share price performance over the longer term. But to understand HCR better, we need to consider many other factors. Like risks, for instance. Every company has them, and we've spotted 2 warning signs for HCR (of which 1 is potentially serious!) you should know about.

年內醫護接受者股東下跌 13%,甚至較市場虧損 5.1% 更差。毫無疑問,這令人失望,但股票在更強大的市場中表現可能更好。很高興看到過去三個月有 54% 的小反彈。讓我們只希望這不是令人擔憂的「死貓反彈」(這將表明進一步下降)。跟踪長期的股價表現總是很有趣。不過,要更好地了解醫護接受者,我們還需要考慮許多其他因素。例如,就像風險一樣。每個公司都有它們,我們已經發現 2 個醫護接受者的警告標誌 (其中 1 個潛在是嚴重的!)你應該知道

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

如果您想與管理層一起購買股票,那麼您可能會喜歡這個 自由 公司名單。(提示:內部人士一直在購買它們)。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CN exchanges.

請注意,本文中引用的市場回報反映了當前在 CN 交易所交易的股票的市場加權平均回報率。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?關注內容? 取得聯繫 直接與我們聯繫。 或者,通過電子郵件發送電子郵件給編輯團隊。
這篇文章由簡單牆聖是一般性質. 我們僅使用公正的方法,根據歷史數據和分析師預測提供評論,我們的文章並不打算作為財務建議。 它並不構成購買或出售任何股票的建議,也不會考慮您的目標或您的財務狀況。我們的目標是為您帶來由基本數據驅動的長期集中分析。請注意,我們的分析可能不會考慮最新的價格敏感公司公告或定性材料。簡易華街在提及的任何股票中都沒有倉位。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論